Dennis E. Raglin

Partner

Practice Groups and Client Sectors:

Litigation

Areas of Focus:

Proposition 65/Green Chemistry, Medical Devices, Products Liability, Complex Litigation, Life Sciences
Dennis E. Raglin

Education

University of California

Davis School of Law, J.D.

University of California

Riverside. B.A., cum laude

Bars & Courts

California

U.S. District Court (C.D. Cal.)

U.S. District Court (E.D. Cal.)

U.S. District Court (N.D. Cal.)

U.S. District Court (S.D. Cal.)

Professional Experience

Dennis Raglin is a member of Rimon’s Litigation practice where he specializes in defending clients in the areas of products liability, including medical device and pharmaceutical, and in all types of general and complex litigation.  He also counsels and defends clients in California’s Proposition 65 right-to-know chemical warnings law and green chemistry regulations in California and nationwide.  Mr. Raglin has over twenty years of extensive litigation experience and has tried cases to verdict, including to defense verdict, and has achieved dismissals and summary judgments, as well as favorable settlements in mediation and arbitration, for a diverse group of clients.  In his Proposition 65 and green chemistry practice, in addition to defending clients who have received notices of violation or are involved in litigation, Mr. Raglin advises companies large and small before litigation on minimizing their risk and employing best practices to ensure compliance with these often complicated laws.

Mr. Raglin’s wealth of experience has seen him represent a wide variety of clients in the fields of: medical device and pharmaceutical (both over-the-counter and prescription regulated by the FDA); automobiles; heavy equipment and power tools; food and dietary supplements; apparel and footwear; sporting goods; home furnishings; and cosmetics and personal care.  He has also defended numerous clients in all types of litigation, including: personal injury cases involving catastrophic injuries and death; premises liability; contract disputes; and government entities sued for statutory violations.  His clients have included Fortune 500 and international corporations, insurance carriers, wineries, retail establishments, government agencies, and small emerging companies.  Regardless of the client, Mr. Raglin’s philosophy is to first understand it and its business, and to listen to what the client’s needs and goals are for the litigation at the outset – and then he works continuously throughout the course of his representation to effectively and efficiently achieve those goals to get the best result for the client.

Mr. Raglin has been both a speaker and an author of numerous articles in his fields of practice. In the area of Proposition 65 and green chemistry, he has authored several articles on aspects of these regulations and he regularly prepares “alerts” to keep firm clients apprised of proposed changes in the law and explain how they impact business.  He has written and been a speaker in the areas of products liability, including analyzing compliance with FDA regulations governing medical device and pharmaceutical companies and evaluating products liability theories in expected future litigation against companies related to climate change.  He has also been a repeat speaker regarding aspects of FDA-related rules and best practice for life science companies at CBI’s “Medical Communications and Information Summit.”  His articles have been featured in a variety of national and state publications, including Bloomberg, Food and Safety Magazine and The San Francisco Daily Journal. 

Prior to joining Rimon, Mr. Raglin was a partner at Sedgwick LLP in San Francisco where he was a member of the Life Science practice group and chaired the firm’s Proposition 65 and Green Chemistry practice group.


REPRESENTATIVE MATTERS

  • Obtained defense verdict following a seven-week trial for manufacturer client sued for negligent design and failure to warn regarding its electrocautery machine.  Parents of young plaintiff sought $26 million in damages.
  • Defended famous Napa Valley wine grower and winery in catastrophic injury and premises liability case, achieving favorable settlement on eve of trial.
  • Achieved favorable settlement for medical device client in a wrongful death case where parents of a child utilizing client’s electric oxygen machine sought significant damages alleging design defect following power outage.
  • Obtained dismissal for client following filing summary judgment motion showing the product had been negligently repaired by unknown third party.
  • Represented national nutritional company in Proposition 65 litigation involving plaintiff’s contention that a warning was required for a chemical found in client’s baby foods.
  • Defended multiple furniture distributors and manufacturers in protracted Proposition 65 litigation involving chemicals present in foam padding and assisted in developing of compliance program as part of settlement.
  • Defended and successfully resolved, after years-long litigation by prior counsel, a complex class action against state government agency where class of former prison inmates alleged violation of state law regarding certain payments owed them. 

PUBLICATIONS AND SPEAKING ENGAGEMENTS

  • Speaker, "Best practices for compliance with the FDA’s guidance on the use of social media" CBI’s “MedComm 2016”: 6th Medical Communication and Information Summit. (October 27, 2016)
  • Author, "The New Toxic Substances Control Act: How we got here, the highlights of the new law and how it impacts companies and their products” article published in Westlaw Journal Environmental, Expert Analysis (September 28, 2016)
  • Author, "NDIs: When to file, what FDA wants to see, and how companies can protect themselves", article published in Nutraingredients-USA (September 16, 2016)
  • Speaker, “Best Practices to Ensure Compliance in Scientific Exchange,” Medical Communications and Information Summit 2015 (November 16, 2015).
  • “Proposition 65’s ‘Naturally Occurring’ Exemption,” Food Safety Magazine (August/September 2015).
  • “Following the Social Media Rules for Pharma and Medical Device Companies,” The Recorder (March 30, 2014).
  • Speaker, “Current Status of FDA Guidance on Social Media,” Medical Communications and Information Summit 2014 (October 8, 2014).
  • “Green Chemistry Regulatory Push Among States Continues,” Law360 (June 16, 2014).
  • “Update on Proposed Changes to Prop. 65 Warning Regulations – Better or Worse?” Sedgwick’s Prop 65 Update (Spring 2014).
  • “California’s New Green Chemistry Regulations Taking Effect,” Sedgwick’s CA Prop 65 Client Alert and Toxic Tort and Environmental Law Update (August 2013).
  • “California’s New ‘Safer Consumer Products’ Law – Prop. 65 on Steroids,” Sedgwick’s Prop 65 Update (Spring 2013).
  • “New ‘Green Chemistry’ Regulations on the Way…Still,” Daily Journal (February 2013).
  •  “States Move Forward with ‘Green Chemistry’ Chemical Reporting Laws and Incur Confusion, Potentially Significant Costs in Their Wake,” Bloomberg BNA Toxics Law Reporter (December 2012). 
  • “Climate Change, the Next ‘Hot’ Topic in Product Liability Litigation,” For the Defense, Defense Research Institute (December 2008).

HONORS AND AWARDS

2015 and 2016 “Mentor of the Year,” Bay Area Lawyers for Individual Freedom

Affiliations, Activities and Accomplishments

  • Admitted to practice in all federal districts in California.a
  • Member, State Bar of California
  • Member, Bar Association of San Francisco, Sections on Litigation and Environmental Law
  • Member, American Bar Association, Section on Litigation